Bill Text: FL S0392 | 2023 | Regular Session | Introduced
Bill Title: Atherosclerotic Cardiovascular Disease
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2023-05-02 - Adopted, companion bill(s) passed, see HR 8069 (Adopted) [S0392 Detail]
Download: Florida-2023-S0392-Introduced.html
Florida Senate - 2023 (NP) SR 392
By Senator Burton
12-00543-23 2023392__
1 Senate Resolution
2 A resolution recognizing the urgent need for the
3 expansion of existing comprehensive cardiovascular
4 screening programs and for the creation of new
5 initiatives to allow for earlier identification of
6 patients at risk of cardiovascular events to decrease
7 the number of deaths attributable to atherosclerotic
8 cardiovascular disease.
9
10 WHEREAS, cardiovascular disease is the leading cause of
11 death in the United States, and
12 WHEREAS, in 2019, about 21 million patients were diagnosed
13 with atherosclerotic cardiovascular disease (ASCVD), making them
14 at risk for a cardiovascular event, and
15 WHEREAS, ASCVD is linked to the build-up of cholesterol in
16 the arteries, and the risk of associated events can be modified
17 by lowering low-density lipoprotein cholesterol (LDL-C), and
18 WHEREAS, it is estimated that in 2019 more than 102 million
19 Americans 20 years of age or older had total cholesterol levels
20 that exceeded what is considered the healthy range, and
21 WHEREAS, in 2022, some 43.1 million Americans were being
22 treated with lipid-lowering therapies to manage cardiovascular
23 risk, and
24 WHEREAS, that year, only 20 percent of people with ASCVD
25 who were taking statins, one of the leading lipid-lowering
26 therapies, achieved healthy levels of LDL-C, and
27 WHEREAS, ASCVD has a substantial economic impact on our
28 society, with national expenditures for the prevention and
29 treatment of ASCVD totaling $126 billion in 2015, a number that
30 is projected to reach $309 billion in 2035, and
31 WHEREAS, in Florida, more than 1.65 million adults were
32 diagnosed and told by a health professional in 2019 that they
33 had angina or coronary artery disease or had suffered a stroke
34 or heart attack, all of which are manifestations of ASCVD, and
35 WHEREAS, Centers for Disease Control (CDC) data shows that
36 in that same year, ASCVD was reported as an underlying cause of
37 death for 34,781 Floridians, and CDC survey data compiled in
38 that period shows that 814,700 Florida adults reported having
39 experienced a heart attack and 628,900 reported having
40 experienced a stroke in their lifetimes, and
41 WHEREAS, one report estimates that Floridians spend $9.64
42 billion annually on direct medical expenses for ASCVD care, NOW,
43 THEREFORE,
44
45 Be It Resolved by the Senate of the State of Florida:
46
47 That the extraordinarily high cost to Floridians of
48 atherosclerotic cardiovascular disease is recognized and that,
49 in collaboration with the Federal Government, as appropriate,
50 state agencies are encouraged to expand comprehensive
51 cardiovascular screening programs to allow for earlier
52 identification of patients at risk for cardiovascular events.
53 BE IT FURTHER RESOLVED that the activities implemented by
54 the Department of Health and its partners to support the overall
55 strategies of tracking and monitoring clinical quality measures,
56 implementing team-based care, and linking community resources
57 and clinical services are recognized as is the importance of
58 vigilance in the administration of the department’s HeartHealth+
59 Program to accelerate quality improvements in the care rendered
60 to patients who are at risk of or who have symptoms of ASCVD so
61 that screening, treatment, monitoring, and improved health
62 outcomes are achieved.
